Philips growth spurred by COVID-19 demand and distant care

By Bart H. Meijer AMSTERDAM (Reuters) - Health technology company Philips saw sales and profits jump in the third quarter, as the COVID-19 pandemic spurred demand for hospital equipment needed to help patients battling the disease. Amsterdam-based Philips on Monday said comparable sales rose 10% to 4.98 billion euros ($5.8 billion) in the July-September period, while core profits improved by almost a third to 769 million euros.

Reuters October 20, 2020 00:06:15 IST
Philips growth spurred by COVID-19 demand and distant care

COVID-19 demand and distant care" src="https://images.firstpost.com/wp-content/uploads/reuters/10-2020/20/2020-10-19T062730Z_2_LYNXMPEG9I0ER_RTROPTP_2_PHILIPS-RESULTS.jpg" alt="Philips growth spurred by COVID19 demand and distant care" width="300" height="225" />

By Bart H. Meijer

AMSTERDAM (Reuters) - Health technology company Philips saw sales and profits jump in the third quarter, as the COVID-19 pandemic spurred demand for hospital equipment needed to help patients battling the disease.

Amsterdam-based Philips on Monday said comparable sales rose 10% to 4.98 billion euros ($5.8 billion) in the July-September period, while core profits improved by almost a third to 769 million euros.

Profits and sales easily beat analysts' expectations, taking Philips shares up 2.9% at 0800 GMT in Amsterdam.

Growth was mainly driven by a 42% increase in sales at the connected care division, which makes monitoring and respiratory care devices used to treat COVID-19 patients and other appliances which allow carers to work remotely.

Like competitors such as Germany's Siemens Healthineers, Philips' results were hit hard in the first half of 2020, as the pandemic caused hospitals to delay the installation of new equipment and crippled demand for consumer products.

But after the first shock of the coronavirus outbreak, Philips began to see a structural change at hospitals, Chief Executive Frans van Houten said, as they increased demand for devices that allow for remote patient monitoring.

These range from appliances for teleconsults to platforms for radiologists to diagnose patients while working from home and for monitoring patients on intensive care units without having to be by their side.

"There is a structural higher demand for the healthcare informatics that Philips has already invested in for several years and now we see the validation of that strategy", the CEO said.

NEW TARGETS

This structural shift will be one of the main drivers for future growth, Van Houten said, as Philips updated its targets for the years to come.

Philips said it expected average sales growth of 5% to 6% per year between 2021 and 2025, with the adjusted EBITA margin improving by 60 to 80 basis points each year.

The company's profit margin jumped to 15.4% in the third quarter, up from 12.4% a year earlier, and is now expected to reach the "high teens" by 2025, it said.

For 2021, however, Philips predicted "low-single-digit growth", as demand for COVID-19 equipment is expected to cool down.

Philips cut its outlook for 2020 in August, after the U.S. Department of Health cancelled most of an order for 43,000 ventilators.

The company on Monday maintained its outlook for moderate sales growth and a stable EBITA margin for the whole of this year.

($1 = 0.8540 euros)

(Reporting by Bart Meijer; Editing by Muralikumar Anantharaman and Richard Pullin/Emelia Sithole-Matarise)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

Global Markets: Stocks ascend to record on economic recovery, vaccine outlook
Business

Global Markets: Stocks ascend to record on economic recovery, vaccine outlook

By Chuck Mikolajczak NEW YORK (Reuters) - A gauge of global stocks hit a record and oil prices jumped on Monday as the newest positive data for a potential COVID-19 vaccine and signs of economic recovery in Asia boosted sentiment. U.S. stocks advanced, with the Dow Industrials setting a record as it neared the 30,000 mark for the first time, after pharma company Moderna said its prospective vaccine was 94.5% effective in preventing the illness, which has crushed economies across the globe

Airbnb IPO filing shows third-quarter earnings beating virus with cost cuts, new focus
Business

Airbnb IPO filing shows third-quarter earnings beating virus with cost cuts, new focus

By Anirban Sen and Joshua Franklin (Reuters) - Airbnb Inc's initial public offering (IPO) registration showed on Monday that the home rental startup turned a profit in the third quarter despite the COVID-19 pandemic, as it gears up for one of the most anticipated stock market debuts in recent years. The filing, published ahead of Airbnb's anticipated stock market debut in December, showed a dramatic recovery in its fortunes, after the coronavirus outbreak dragged down its core home rental business during the first half of the year. The slump forced it to lay off 25% of its workforce in May, suspend marketing activities for the year and seek $2 billion (£1.5 billion) emergency funding from investors, including Silver Lake and Sixth Street Partners, at a valuation of $18 billion

Biden says U.S., allies need to set global trade rules to counter China's influence
Business

Biden says U.S., allies need to set global trade rules to counter China's influence

By David Lawder WASHINGTON (Reuters) - U.S. President-elect Joe Biden said on Monday the United States needed to negotiate with allies to set global trading rules to counter China's growing influence but declined to say whether he would join a new China-backed Asian trade pact signed on Sunday.